Latest Posts › Food and Drug Administration (FDA)

Share:

Artificial Intelligence Briefing: House Launches Bipartisan AI Task Force

The House of Representatives aims to keep the U.S. at the leading edge of AI policy and innovation with a bipartisan task force while the FTC considers expanding a rule to crack down on AI impersonation. Meanwhile, a recent...more

COVID-19 Weekly Newsletter: New Vaccine EUA Expected

Updates on vaccines for young children and a massive study on the efficacy of mask-wearing in schools headline this week’s COVID-19 news....more

COVID-19 Weekly Newsletter: A Fourth Vaccine Dose?

Two prominent vaccine manufacturers submitted requests for authorization of an additional COVID-19 booster dose this week. Meanwhile, as case rates rise in Europe and China, U.S. public health officials take stock of what to...more

COVID-19 Weekly Newsletter: Pediatric COVID-19 Patients

A number of recent studies have sought to identify commonalities among COVID-19 patients under the age of 18 who have required hospitalization. In addition, many new studies have worked to measure the impact of the COVID-19...more

COVID-19 Weekly Newsletter: “Mix-and-Match” Vaccinations Safe, Effective

This week, early findings of an NIH-backed study were released — showing that a combination of doses from any authorized vaccines is safe and effective. Meanwhile, the Department of Labor shifts focus to a traditional...more

COVID-19 Weekly Newsletter: CDC Expands Booster Recommendation

As 2022 gets underway, public health agencies have been busy updating guidelines and working to expand vaccine access as health care providers and researchers contend with the now-dominant Omicron variant. ‘Flurona’ Case...more

COVID-19 Weekly Newsletter: What Do We Know About the Omicron Variant?

The Omicron variant has prompted considerable concern and uncertainty in the COVID-19 response, as public health leaders continue to advocate for vaccines and booster shots and researchers make progress in the development of...more

COVID-19 Weekly Newsletter: Booster Shots Get FDA, CDC Greenlight

Major developments in vaccine authorizations and mandates continue in the U.S., while the surge in Europe has prompted one country to implement a lockdown — and also declare a national vaccine mandate. mRNA COVID-19...more

COVID-19 Weekly Newsletter: Average Case Rates Drop From Delta Wave’s Heights

This week’s newsletter details the latest developments in the process of approving COVID-19 vaccines for children ages 5-11, a vaccine that produced promising clinical results, and new studies revealing insights about...more

COVID-19 Weekly Newsletter: Additional Booster Shots Recommended as FDA Prepares to Evaluate Vaccines for Younger Children

Booster Shot Endorsements - Last week, the U.S. Food and Drug Administration (FDA) advisory committee endorsed one of the mRNA COVID-19 vaccines and the single-dose vaccine to be used as a booster shot. This week, FDA...more

COVID-19 Weekly Newsletter: FDA Considers COVID-19 Pill, Travel Restrictions To Be Lifted

A new submission for a Food and Drug Administration (FDA) emergency use authorization (EUA), new guidance for travelers entering the U.S. and continued studies into the efficacy of booster shots headlined this week’s...more

COVID-19 Weekly Newsletter: A Trio of Potential EUAs

In the coming weeks, the Food and Drug Administration (FDA) will be contemplating three noteworthy emergency use authorizations (EUA). Meanwhile, public health authorities continue to work to assuage public skepticism toward...more

COVID-19 Weekly Newsletter: A Pill To Treat COVID-19?

A promising new COVID-19 treatment grabbed headlines this week, along with new updates on one mRNA vaccine manufacturer’s path to potentially seeking Food and Drug Administration (FDA) approval on vaccines for children...more

COVID-19 Weekly Newsletter: Domestic and International Vaccine News

Clinical trials and public health recommendations relating to booster vaccines and potential vaccines for children under the age of 12 continue to be front and center in the United States’ domestic COVID-19 response....more

COVID-19 Weekly Newsletter: Updates on Vaccines for Children and Potential Authorization for Booster Shots

Amid continued spread of the Delta variant and sobering new studies about the toll COVID-19 has exacted on medical staff, vaccine manufacturers and public health leaders continue to seek solutions — including efforts to...more

COVID-19 Weekly Newsletter: Biden Announces New Pandemic Plan

On September 9, President Biden announced a new six-pronged plan to address COVID-19, which includes bold steps aimed at increasing vaccination rates. Biden’s Path Out of the Pandemic Plan - On Thursday, President...more

COVID-19 Weekly Newsletter: EU Restricts Travel, U.S. Boosts Vaccine Supply Chain

The European Union removed the U.S. from its safe travel list earlier this week, as the Biden administration took measures to bolster the vaccine supply chain to meet the anticipated rise in demand. Children Account for...more

COVID-19 Weekly Newsletter: Full FDA Approval

The COVID-19 vaccine approval process reached a major milestone, but the fourth U.S. wave of the COVID-19 virus has prompted some sobering projections about the future of the pandemic. COVID-19 Vaccine Receives Full FDA...more

COVID-19 Weekly Newsletter: Booster Shots Continue To Gain Steam

Recent announcements on the prospect of booster shots for all vaccinated Americans, a vaccine mandate for staff at federally funded nursing homes and an encouraging uptick in vaccinations marked an eventful week in the...more

COVID-19 Weekly Newsletter: Response to Delta Variant Intensifies

FDA Authorizes Booster Shots for Immunocompromised - The United States Food and Drug Administration updated its emergency use authorizations for two currently authorized COVID-19 vaccines on Thursday, sanctioning third...more

COVID-19 Weekly Newsletter: Formidable Delta Variant Prompts Vaccine Mandates

Vaccinated Individuals Infected With Delta Variant May Carry as Much Virus as Unvaccinated - The U.S. Centers for Disease Control and Prevention (CDC) updated their mask guidance on July 27, 2021, recommending that...more

COVID-19 Weekly Newsletter: CDC Updates Guidance

New federal guidance on masking and testing highlighted an eventful week in the COVID-19 response, as government authorities work to respond to the rising transmission of the Delta variant. CDC Updates Masking and...more

COVID-19 Weekly Newsletter: Cases on the Rise in All 50 States

Cases on the Rise in All 50 States This week marks the first time in months that all 50 states are seeing a rise in cases, with more than 30 states seeing at least a 50% increase over the previous week. The U.S. Centers for...more

COVID-19 Weekly Newsletter: Variants and Vaccine Hesitancy

As the delta variant becomes more prominent in the U.S., public health authorities look for ways to address vaccine hesitancy, and the scientific community seeks to better understand viruses — as our list of identified...more

COVID-19 Weekly Newsletter: Delta Variant a Threat to the Unvaccinated

Delta Variant Accounts for 20% of Samples Tested - The delta variant, first identified in India a few months ago and now present in 90-plus countries, is more transmissible and deadly than previous variants that have...more

44 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide